In its initial July Safety Alert, the New Jersey-based medical device company Medtronic announced that it was recalling ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Insulin pump therapy, also known as continuous subcutaneous ... including Roche Diagnostics, Sanofi, Abbott, and Medtronic. G.A.F. is President and CEO of Kinexum, which advises multiple health ...

Medtronic’s cardiovascular and neuroscience segments show steady mid-single-digit growth annually. Recent recalls of insulin pumps may hinder growth in Medtronic's diabetes business, despite ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Que Dallara, EVP and president of Medtronic Diabetes, wrote on LinkedIn: ...